Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity

v3.19.3
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-controlling Interest
Balance at period start (in shares) at Dec. 31, 2017   57,450,056 12,749,415        
Balance, at period start at Dec. 31, 2017 $ 436,670 $ 287 $ (47,042) $ 556,257 $ 624 $ (73,854) $ 398
Increase (decrease) in shareholders' equity              
Adoption of ASC 606 9,217         9,217  
Exercise of stock options (in shares)   162,857          
Exercise of stock options 2,404 $ 1   2,403      
Issuance of common stock - vesting of restricted stock units (in shares)   503,668          
Issuance of common stock - vesting of restricted stock units 2 $ 2          
Stock-based compensation expense 8,495     8,495      
Purchase of treasury stock for stock-based tax withholdings (in shares)     (166,217)        
Purchase of treasury stock for stock-based tax withholdings (9,296)   $ (9,296)        
Issuance of non-controlling units in private company 873           873
Foreign currency translation gain (loss) (327)       (327)    
Net income (loss) 8,002         8,104 (102)
Balance at period end (in shares) at Mar. 31, 2018   58,116,581 12,915,632        
Balance, at period end at Mar. 31, 2018 456,040 $ 290 $ (56,338) 567,155 297 (56,533) 1,169
Balance at period start (in shares) at Dec. 31, 2017   57,450,056 12,749,415        
Balance, at period start at Dec. 31, 2017 436,670 $ 287 $ (47,042) 556,257 624 (73,854) 398
Increase (decrease) in shareholders' equity              
Foreign currency translation gain (loss) (2,471)            
Net income (loss) 4,522            
Balance at period end (in shares) at Sep. 30, 2018   58,716,254 13,039,119        
Balance, at period end at Sep. 30, 2018 511,915 $ 293 $ (64,926) 637,639 (1,847) (59,105) (139)
Balance at period start (in shares) at Mar. 31, 2018   58,116,581 12,915,632        
Balance, at period start at Mar. 31, 2018 456,040 $ 290 $ (56,338) 567,155 297 (56,533) 1,169
Increase (decrease) in shareholders' equity              
Exercise of stock options (in shares)   12,166          
Exercise of stock options 136     136      
Issuance of common stock - vesting of restricted stock units (in shares)   253,279          
Issuance of common stock - vesting of restricted stock units 1 $ 1          
Stock-based compensation expense 10,476     10,476      
Purchase of treasury stock for stock-based tax withholdings (in shares)     (90,800)        
Purchase of treasury stock for stock-based tax withholdings (5,099)   $ (5,099)        
Issuance of Convertible Notes due 2023, net of offering costs 46,611     46,611      
Foreign currency translation gain (loss) (1,036)       (1,036)    
Net income (loss) (5,991)         (5,526) (465)
Balance at period end (in shares) at Jun. 30, 2018   58,382,026 13,006,432        
Balance, at period end at Jun. 30, 2018 501,138 $ 291 $ (61,437) 624,378 (739) (62,059) 704
Increase (decrease) in shareholders' equity              
Exercise of stock options (in shares)   174,445          
Exercise of stock options 2,659 $ 1   2,658      
Issuance of common stock - vesting of restricted stock units (in shares)   159,783          
Issuance of common stock - vesting of restricted stock units 1 $ 1          
Stock-based compensation expense 10,603     10,603      
Purchase of treasury stock for stock-based tax withholdings (in shares)     (32,687)        
Purchase of treasury stock for stock-based tax withholdings (3,489)   $ (3,489)        
Issuance of non-controlling units in private company (400)           (400)
Foreign currency translation gain (loss) (1,108)       (1,108)    
Net income (loss) 2,511         2,954 (443)
Balance at period end (in shares) at Sep. 30, 2018   58,716,254 13,039,119        
Balance, at period end at Sep. 30, 2018 511,915 $ 293 $ (64,926) 637,639 (1,847) (59,105) (139)
Balance at period start (in shares) at Dec. 31, 2018   61,238,898 13,117,098        
Balance, at period start at Dec. 31, 2018 632,602 $ 306 $ (67,858) 761,128 (994) (58,882) (1,098)
Increase (decrease) in shareholders' equity              
Exercise of stock options (in shares)   200,326          
Exercise of stock options 3,163 $ 1   3,162      
Issuance of common stock - vesting of restricted stock units (in shares)   479,479          
Issuance of common stock - vesting of restricted stock units 2 $ 2          
Acquisition of business (in shares)   15,755          
Acquisition of business 772     772      
Stock-based compensation expense 12,864     12,864      
Purchase of treasury stock for stock-based tax withholdings (in shares)     (160,456)        
Purchase of treasury stock for stock-based tax withholdings (9,819)   $ (9,819)        
Foreign currency translation gain (loss) 222       222    
Net income (loss) (18,268)         (18,185) (83)
Balance at period end (in shares) at Mar. 31, 2019   61,934,458 13,277,554        
Balance, at period end at Mar. 31, 2019 621,538 $ 309 $ (77,677) 777,926 (772) (77,067) (1,181)
Balance at period start (in shares) at Dec. 31, 2018   61,238,898 13,117,098        
Balance, at period start at Dec. 31, 2018 632,602 $ 306 $ (67,858) 761,128 (994) (58,882) (1,098)
Increase (decrease) in shareholders' equity              
Foreign currency translation gain (loss) (1,124)            
Net income (loss) (20,619)            
Balance at period end (in shares) at Sep. 30, 2019   65,883,873 13,430,052        
Balance, at period end at Sep. 30, 2019 860,918 $ 329 $ (87,555) 1,030,861 (2,118) (79,254) (1,345)
Balance at period start (in shares) at Mar. 31, 2019   61,934,458 13,277,554        
Balance, at period start at Mar. 31, 2019 621,538 $ 309 $ (77,677) 777,926 (772) (77,067) (1,181)
Increase (decrease) in shareholders' equity              
Exercise of stock options (in shares)   114,109          
Exercise of stock options 1,751 $ 1   1,750      
Issuance of common stock - vesting of restricted stock units (in shares)   182,390          
Issuance of common stock - vesting of restricted stock units 1 $ 1          
Acquisition of business (in shares)   3,184,713          
Acquisition of business 222,484 $ 16   222,468      
Stock-based compensation expense 13,434     13,434      
Purchase of treasury stock for stock-based tax withholdings (in shares)     (67,960)        
Purchase of treasury stock for stock-based tax withholdings (6,143)   $ (6,143)        
Foreign currency translation gain (loss) 112       112    
Net income (loss) 613         893 (280)
Balance at period end (in shares) at Jun. 30, 2019   65,415,670 13,345,514        
Balance, at period end at Jun. 30, 2019 853,790 $ 327 $ (83,820) 1,015,578 (660) (76,174) (1,461)
Increase (decrease) in shareholders' equity              
Exercise of stock options (in shares)   225,414          
Exercise of stock options 2,115 $ 1   2,114      
Issuance of common stock - vesting of restricted stock units (in shares)   242,789          
Issuance of common stock - vesting of restricted stock units 1 $ 1          
Stock-based compensation expense 13,169     13,169      
Purchase of treasury stock for stock-based tax withholdings (in shares)     (84,538)        
Purchase of treasury stock for stock-based tax withholdings (3,735)   $ (3,735)        
Foreign currency translation gain (loss) (1,458)       (1,458)    
Net income (loss) (2,964)         (3,080) 116
Balance at period end (in shares) at Sep. 30, 2019   65,883,873 13,430,052        
Balance, at period end at Sep. 30, 2019 $ 860,918 $ 329 $ (87,555) $ 1,030,861 $ (2,118) $ (79,254) $ (1,345)